Brief: Sutro Biopharma Q1 Revenue USD 17.399 Million
08/05/2025 21:32
May 08 (Reuters) - Sutro Biopharma Q1 operating income USD -68.514 million. Q1 operating expenses USD 85.913 million Q1 net income USD -75.968 million Q1 basic EPS USD -0.91
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates